Seeking people who been diagnosed with Multiple Sclerosis (MS) or a similar immune disorder of the central nervous system or their immediate family members for a study to better understand what causes these diseases and perhaps improve treatment.
10 Studies found
Seeking men and women whose multiple sclerosis has not responded well to previous treatment and whose doctor has decided to start treatment with cladribine tablets and stop treatment with an injectable drug.
Seeking men and women with relapsing multiple sclerosis whose doctors has decided to start treatment with clabridine tablets because other pills were not working well.
Seeking men and women with Multiple Sclerosis for a study of the role of stress in multiple sclerosis and whether an 8-week mindfulness-based stress reduction (MBSR) program effects your sense of well-being, stress level, and how it may change your brain.
Seeking men and women with multiple sclerosis for a study of an investigational drug for multiple sclerosis. This drug has not been tested in humans before.
Seeking women and men who have started ocrelizumab treatment for their Multiple Sclerosis (MS) within the past month or people whose MS is being being treated with therapies other than ocrelizumab for a study looking at the incidence of cancer in the future.
This is a registry to collect medical record information from people living with Multiple Sclerosis (MS) to better understand the disease and develop new treatments
Questionnaire Study Of The Long-Term Safety And Effectiveness Of The Drug Tecfidera For Multiple Sclerosis (Ms)
To collect data on patient who are receiving dimetyl fumarate as part of their routine care for multiple sclerosis
Long Term Follow-up Study for Multiple Sclerosis Patients who Completed the Alemtuzumab Extension Study
Seeking men and women with Multiple Sclerosis who completed the alemtuzumab Extension study for a new study of the long-term safety and effectiveness of alemtuzumab.
Newly diagnosed (within 6 months) people with Multiple Sclerosis (MS) sought for a trial comparing "first line" (traditional) with "second line" (aggressive) treatments in preventing disability. This is a pragmatic trial which means that even though participants will be randomly assigned a treatment group, they and their doctor can change their treatment if needed.